Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Join us tomorrow for a webinar sponsored by Medable as we explore challenges of drug innovation in the cardiometabolic space and how connected devices could make evidence collection less costly and more efficient to support regulatory evaluation and approvals.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A recent webinar hosted by MedCity News and sponsored by BioT shared insights on some of the ingredients to successful creation and execution of remote patient monitoring solutions supported by a cloud-based connected care platform with speakers from BioT and Abbott.
In a recent webinar sponsored by 100Plus, the healthcare company provided a roadmap on how their RPM program works, including device deployment, collaboration with clinicians, implementation and reimbursement.
The webinar on November 18th at 1pm ETwill address considerations around building a personalized connected care solution and how you can achieve it in a very short timeframe.
Digital health thought leader Mark Tarby, BrightInsight vice president of regulatory and quality management systems, shared his take on what the EU MDR means for connected devices, Software as a Medical Device (SaMD), and the go-to market strategies for the companies behind them.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Join us on July 21st and learn how to connect patients and caregivers in a way to extend and provide the best quality of life.
After Withings co-founder Eric Carreel bought the connected device company back from Nokia two years ago, the company has charted a more clinical course. With $60 million in new funding, Withings plans to build out a remote monitoring program for its medical devices.
Cue Health, a startup developing a connected testing device, closed a $100 million series C round. The company recently submitted its system to the FDA for emergency use authorization to be used for onsite Covid-19 testing.
Kal Patel, MD, CEO and co-founder of BrightInsight, highlighted the value of using a regulated Internet of Things (IoT) infrastructure to host and manage digital health products in an interview with MedCity News.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Known as CapMedic, the device signals patients to help them use inhalers correctly. Developers hope the feedback mechanism distinguishes the device from other smart inhalers.
Data empowers insight and decisionmaking, so introducing devices that constantly monitor at-risk patients is a definite way to deliver the best possible health outcomes of any situation.
Fitabase CEO Aaron Coleman said he sees the integration being particularly useful to researchers looking at how behavioral recommendations in areas like physical activity and sleep can affect glucose levels to create more tailored care plans for diabetic patients.
Navigate4Me relies on trained care navigators who act as a point person for a patient's healthcare needs by assisting in clinical or administrative tasks, following up on treatment plans and connecting people to social or community-based support like transportation or housing assistance.
The spun off company will be renamed Capsule Technologies and will continue to operate as two separate business entities: Capsule and 2net.